US6057287A
(en)
|
1994-01-11 |
2000-05-02 |
Dyax Corp. |
Kallikrein-binding "Kunitz domain" proteins and analogues thereof
|
US20020064546A1
(en)
*
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
WO1998012274A1
(en)
|
1996-09-23 |
1998-03-26 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
US6258351B1
(en)
*
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
US7642323B2
(en)
|
1997-11-06 |
2010-01-05 |
Nektar Therapeutics |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
CA2316834C
(en)
*
|
1998-01-07 |
2006-01-03 |
Shearwater Polymers, Inc. |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
US7790192B2
(en)
|
1998-08-14 |
2010-09-07 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
GB2341185A
(en)
*
|
1998-09-07 |
2000-03-08 |
Polybiomed Ltd |
Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
|
WO2000015117A1
(en)
|
1998-09-17 |
2000-03-23 |
Focal, Inc. |
Self-cleaning fluid delivery device for medical applications
|
AU773914B2
(en)
|
1999-02-01 |
2004-06-10 |
Eidgenossische Technische Hochschule Zurich |
Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
|
US6958212B1
(en)
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
US6828412B1
(en)
*
|
1999-09-03 |
2004-12-07 |
School Of Pharmacy, University Of London |
Degradable polymers
|
US7037992B2
(en)
*
|
1999-09-29 |
2006-05-02 |
Sri International |
Olefin copolymers containing hydrolytically cleavable linkages and use thereof in degradable products
|
US6288184B1
(en)
*
|
1999-09-29 |
2001-09-11 |
Sri International |
Hydrolytically degradable olefin copolymers
|
JP4344110B2
(ja)
*
|
1999-10-08 |
2009-10-14 |
ネクター セラピューティックス エイエル,コーポレイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
DK1259562T3
(da)
*
|
1999-12-22 |
2006-04-18 |
Nektar Therapeutics Al Corp |
Sterisk hindrede derivater af vandoplöselige polymerer
|
US7291673B2
(en)
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
ES2367891T3
(es)
|
2000-09-29 |
2011-11-10 |
Schering Corporation |
Interleucina-10 pegilada.
|
EP1355965B1
(de)
|
2000-10-19 |
2012-09-19 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Verfahren zur herstellung von blockcopolymeren für multifunktionelle selbstorganisierende systeme
|
US7829074B2
(en)
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
US7265186B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Nektar Therapeutics Al, Corporation |
Multi-arm block copolymers as drug delivery vehicles
|
TWI246524B
(en)
*
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
GB0116143D0
(en)
*
|
2001-07-02 |
2001-08-22 |
Amersham Pharm Biotech Uk Ltd |
Chemical capture reagent
|
EP2305314B1
(de)
|
2001-10-10 |
2015-12-23 |
ratiopharm GmbH |
Neumodulierung und Glykokonjugation von Antikörpern
|
EP2279755B1
(de)
|
2001-10-10 |
2014-02-26 |
ratiopharm GmbH |
Neumodulierung und Glykokonjugation von Fibroblasten-Wachstumsfaktor (FGF)
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
WO2004099231A2
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
EP2298278B1
(de)
|
2002-06-07 |
2015-11-11 |
Dyax Corp. |
Verhinderung und Reduzierung von Blutverlust und Entzündungsreaktion
|
US7153829B2
(en)
|
2002-06-07 |
2006-12-26 |
Dyax Corp. |
Kallikrein-inhibitor therapies
|
US7217254B2
(en)
|
2002-09-20 |
2007-05-15 |
Genzyme Corporation |
Multi-pressure biocompatible agent delivery device and method
|
WO2004035537A2
(en)
|
2002-10-16 |
2004-04-29 |
Euro-Celtique S.A. |
Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
|
US7311926B2
(en)
*
|
2002-12-20 |
2007-12-25 |
Battelle Memorial Institute |
Biocomposite materials and methods for making the same
|
BRPI0408358A
(pt)
|
2003-03-14 |
2006-03-21 |
Neose Technologies Inc |
polìmeros hidrossolúveis ramificados e seus conjugados
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
AU2004240553A1
(en)
|
2003-05-09 |
2004-12-02 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
CA3050564A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Dyax Corp. |
Poly-pegylated protease inhibitors
|
US7786213B2
(en)
*
|
2003-10-15 |
2010-08-31 |
The Regents Of The University Of California |
Biomacromolecule polymer conjugates
|
CN107090025A
(zh)
|
2003-11-05 |
2017-08-25 |
达纳-法伯癌症研究所股份有限公司 |
稳定的α螺旋肽及其用途
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US7842661B2
(en)
|
2003-11-24 |
2010-11-30 |
Novo Nordisk A/S |
Glycopegylated erythropoietin formulations
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
EP1722834B1
(de)
*
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrix mit natürlich vorkommendem vernetztem proteingerüst
|
US7842667B2
(en)
|
2003-12-22 |
2010-11-30 |
Regentis Biomaterials Ltd. |
Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
|
CA2552892C
(en)
|
2004-01-08 |
2014-08-05 |
Neose Technologies, Inc. |
O-linked glycosylation of peptides
|
WO2005115477A2
(en)
|
2004-04-13 |
2005-12-08 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
US7282584B2
(en)
|
2004-06-16 |
2007-10-16 |
Straumann Holding Ag |
Methylene blue
|
ES2299776T3
(es)
|
2004-06-16 |
2008-06-01 |
Straumann Holding Ag |
Membrana de barrera.
|
US7968085B2
(en)
|
2004-07-05 |
2011-06-28 |
Ascendis Pharma A/S |
Hydrogel formulations
|
EP1625856A1
(de)
*
|
2004-08-13 |
2006-02-15 |
Complex Biosystems GmbH |
Hydrogel Polymer Prodroge Konjugate
|
EP2111872B1
(de)
|
2004-07-05 |
2020-12-23 |
Ascendis Pharma GmbH |
Hydrogel-konjugate
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
US8268967B2
(en)
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
US7235530B2
(en)
|
2004-09-27 |
2007-06-26 |
Dyax Corporation |
Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
|
EP1814573B1
(de)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
JP2008530305A
(ja)
|
2005-02-09 |
2008-08-07 |
タイコ ヘルスケア グループ エルピー |
合成封止剤
|
US20060222596A1
(en)
|
2005-04-01 |
2006-10-05 |
Trivascular, Inc. |
Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
EP1871795A4
(de)
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
Zusammensetzungen und verfahren zur herstellung von glycosylierungsmutanten eines proteaseresistenten menschlichen wachstumshormons
|
US20080255026A1
(en)
|
2005-05-25 |
2008-10-16 |
Glycopegylated Factor 1X |
Glycopegylated Factor Ix
|
US9505867B2
(en)
|
2005-05-31 |
2016-11-29 |
Ecole Polytechmique Fédérale De Lausanne |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
WO2007007392A1
(ja)
*
|
2005-07-11 |
2007-01-18 |
Wako Pure Chemical Industries, Ltd. |
新規ポリマー及びこれを用いたコレステロール測定法
|
WO2007011802A1
(en)
|
2005-07-18 |
2007-01-25 |
Nektar Therapeutics Al, Corporation |
Method for preparing branched functionalized polymers using branched polyol cores
|
GB0515625D0
(en)
*
|
2005-07-29 |
2005-09-07 |
Univ Manchester |
Hydrogel particle
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
JP2007112924A
(ja)
*
|
2005-10-21 |
2007-05-10 |
National Institute For Materials Science |
高分子架橋剤及びこの架橋剤を用いたリポソーム又は細胞の架橋体
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
US7597882B2
(en)
|
2006-04-24 |
2009-10-06 |
Incept Llc |
Protein crosslinkers, crosslinking methods and applications thereof
|
US7872068B2
(en)
|
2006-05-30 |
2011-01-18 |
Incept Llc |
Materials formable in situ within a medical device
|
JP2009541333A
(ja)
|
2006-06-23 |
2009-11-26 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
修飾リボヌクレアーゼ
|
EP2049151A4
(de)
*
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung von krebs
|
US8268948B2
(en)
*
|
2006-07-21 |
2012-09-18 |
Nektar Therapeutics |
Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
BRPI0719446A2
(pt)
|
2006-09-28 |
2013-12-10 |
Schering Corp |
Uso de il-10 peguilada para tratar câncer
|
WO2008057683A2
(en)
|
2006-10-03 |
2008-05-15 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
DK2068907T3
(en)
|
2006-10-04 |
2018-01-15 |
Novo Nordisk As |
GLYCEROL BOND PEGYLED SUGAR AND GLYCOPE Peptides
|
US8394483B2
(en)
|
2007-01-24 |
2013-03-12 |
Micron Technology, Inc. |
Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly
|
CA2677045C
(en)
|
2007-01-31 |
2016-10-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
US8083953B2
(en)
|
2007-03-06 |
2011-12-27 |
Micron Technology, Inc. |
Registered structure formation via the application of directed thermal energy to diblock copolymer films
|
US8557128B2
(en)
|
2007-03-22 |
2013-10-15 |
Micron Technology, Inc. |
Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers
|
CA2682174C
(en)
|
2007-03-28 |
2021-04-06 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
KR20100016160A
(ko)
|
2007-04-03 |
2010-02-12 |
바이오제너릭스 에이지 |
글리코페길화 g―csf를 이용하는 치료 방법
|
US8097175B2
(en)
|
2008-10-28 |
2012-01-17 |
Micron Technology, Inc. |
Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure
|
US8294139B2
(en)
|
2007-06-21 |
2012-10-23 |
Micron Technology, Inc. |
Multilayer antireflection coatings, structures and devices including the same and methods of making the same
|
US7959975B2
(en)
|
2007-04-18 |
2011-06-14 |
Micron Technology, Inc. |
Methods of patterning a substrate
|
US8372295B2
(en)
|
2007-04-20 |
2013-02-12 |
Micron Technology, Inc. |
Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
US8404124B2
(en)
|
2007-06-12 |
2013-03-26 |
Micron Technology, Inc. |
Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces
|
US8080615B2
(en)
|
2007-06-19 |
2011-12-20 |
Micron Technology, Inc. |
Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide
|
CA2696208A1
(en)
*
|
2007-08-21 |
2009-02-26 |
Genzyme Corporation |
Treatment with kallikrein inhibitors
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
US8697062B2
(en)
*
|
2007-10-08 |
2014-04-15 |
Quintessence Biosciences, Inc. |
Compositions and methods for ribonuclease-based therapeutics
|
US8999492B2
(en)
|
2008-02-05 |
2015-04-07 |
Micron Technology, Inc. |
Method to produce nanometer-sized features with directed assembly of block copolymers
|
JP5739668B2
(ja)
*
|
2008-02-13 |
2015-06-24 |
ハイパーブランチ メディカル テクノロジー, インコーポレイテッド |
調節可能な分解速度を有する架橋ポリアルキレンイミンヒドロゲル
|
US8101261B2
(en)
|
2008-02-13 |
2012-01-24 |
Micron Technology, Inc. |
One-dimensional arrays of block copolymer cylinders and applications thereof
|
JP5150297B2
(ja)
*
|
2008-02-14 |
2013-02-20 |
ネクター セラピューティックス エイエル,コーポレイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
ES2476690T3
(es)
|
2008-02-27 |
2014-07-15 |
Novo Nordisk A/S |
Moléculas conjugadas del Factor VIII
|
US8425982B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Methods of improving long range order in self-assembly of block copolymer films with ionic liquids
|
US8426313B2
(en)
|
2008-03-21 |
2013-04-23 |
Micron Technology, Inc. |
Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference
|
US8114300B2
(en)
|
2008-04-21 |
2012-02-14 |
Micron Technology, Inc. |
Multi-layer method for formation of registered arrays of cylindrical pores in polymer films
|
US8114301B2
(en)
|
2008-05-02 |
2012-02-14 |
Micron Technology, Inc. |
Graphoepitaxial self-assembly of arrays of downward facing half-cylinders
|
US8575102B2
(en)
*
|
2008-08-01 |
2013-11-05 |
Nektar Therapeutics |
Conjugates having a releasable linkage
|
JP5435536B2
(ja)
*
|
2008-09-04 |
2014-03-05 |
学校法人神奈川大学 |
光分解性ブロックコポリマー
|
CN104961795A
(zh)
|
2008-09-22 |
2015-10-07 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
EP2334695B1
(de)
|
2008-10-01 |
2015-12-23 |
Quintessence Biosciences, Inc. |
Therapeutische ribonukleasen
|
WO2010068432A1
(en)
|
2008-11-25 |
2010-06-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Block copolymers and uses thereof
|
WO2010067378A2
(en)
|
2008-12-08 |
2010-06-17 |
Reliance Life Sciences Pvt. Ltd. |
Hydrogel composition
|
AU2010203712A1
(en)
|
2009-01-06 |
2010-07-15 |
Dyax Corp. |
Treatment of mucositis with kallikrein inhibitors
|
AU2010204648B2
(en)
|
2009-01-14 |
2016-09-01 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
CA2760704C
(en)
|
2009-05-04 |
2017-10-03 |
Incept, Llc |
Biomaterials for track and puncture closure
|
NO2440239T3
(de)
|
2009-06-09 |
2018-02-10 |
|
|
CA2769340C
(en)
|
2009-07-31 |
2018-09-11 |
Harald Rau |
Prodrugs comprising an insulin linker conjugate
|
SG178195A1
(en)
|
2009-07-31 |
2012-03-29 |
Sanofi Aventis Deutschland |
Long acting insulin composition
|
JP4704506B2
(ja)
*
|
2009-08-11 |
2011-06-15 |
財団法人川村理化学研究所 |
有機無機複合ヒドロゲルおよびその製造方法
|
CN102712675A
(zh)
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
US20110081398A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Tyco Healthcare Group Lp |
Multi-mechanism surgical compositions
|
US20110081701A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Timothy Sargeant |
Surgical compositions
|
US8968785B2
(en)
*
|
2009-10-02 |
2015-03-03 |
Covidien Lp |
Surgical compositions
|
JP5552310B2
(ja)
*
|
2009-12-24 |
2014-07-16 |
日清紡ホールディングス株式会社 |
樹脂架橋剤
|
LT2521568T
(lt)
|
2010-01-06 |
2018-12-10 |
Dyax Corp. |
Plazmos kalikreiną surišantys baltymai
|
US8524215B2
(en)
*
|
2010-08-02 |
2013-09-03 |
Janssen Biotech, Inc. |
Absorbable PEG-based hydrogels
|
WO2012021876A2
(en)
|
2010-08-13 |
2012-02-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US8304493B2
(en)
|
2010-08-20 |
2012-11-06 |
Micron Technology, Inc. |
Methods of forming block copolymers
|
EP2438930A1
(de)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrug mit einem exendinbindenden Konjugat
|
WO2012065181A2
(en)
|
2010-11-12 |
2012-05-18 |
Dana Farber Cancer Institute, Inc. |
Cancer therapies and diagnostics
|
BR112013017080A8
(pt)
|
2011-01-06 |
2023-05-09 |
Dyax Corp |
Anticorpo ou fragmento funcional do mesmo que se liga a forma ativa de calicreína do plasma humano, composiçao farmacêutica e método de detecçao de calicreína do plasma em um paciente
|
CN108929375A
(zh)
|
2011-10-18 |
2018-12-04 |
爱勒让治疗公司 |
拟肽大环化合物
|
US8900963B2
(en)
|
2011-11-02 |
2014-12-02 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related structures
|
AU2012362121B2
(en)
|
2011-12-29 |
2017-08-03 |
Dana-Farber Cancer Institute, Inc. |
Stabilized antiviral fusion helices
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
ES2817877T3
(es)
|
2012-02-15 |
2021-04-08 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
JP5953459B2
(ja)
*
|
2012-03-27 |
2016-07-20 |
ネクター セラピューティクス |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
EP2920197B1
(de)
|
2012-09-26 |
2021-03-17 |
President and Fellows of Harvard College |
Prolinblockierte geheftete peptide und verwendungen davon
|
US9087699B2
(en)
|
2012-10-05 |
2015-07-21 |
Micron Technology, Inc. |
Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス,インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
US10081654B2
(en)
|
2013-03-13 |
2018-09-25 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
CA2906572A1
(en)
|
2013-03-15 |
2014-09-25 |
Dana-Farber Cancer Institute, Inc. |
Stabilized ezh2 peptides
|
US10106590B2
(en)
|
2013-03-15 |
2018-10-23 |
Dana-Farber Cancer Institute, Inc. |
BH4 stabilized peptides and uses thereof
|
AU2014227824B2
(en)
|
2013-03-15 |
2018-09-27 |
Dana-Farber Cancer Institute, Inc. |
Stabilized SOS1 peptides
|
JP2016519108A
(ja)
|
2013-04-18 |
2016-06-30 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
インターロイキン−10を疾病及び疾患の治療に用いる方法
|
US9229328B2
(en)
|
2013-05-02 |
2016-01-05 |
Micron Technology, Inc. |
Methods of forming semiconductor device structures, and related semiconductor device structures
|
CN105492460A
(zh)
|
2013-06-14 |
2016-04-13 |
哈佛大学的校长及成员们 |
稳定化多肽胰岛素受体调控剂
|
WO2014204816A2
(en)
|
2013-06-17 |
2014-12-24 |
Armo Biosciences, Inc. |
Method for assessing protein identity and stability
|
WO2015013510A1
(en)
|
2013-07-25 |
2015-01-29 |
Ecole Polytechnique Federale De Lausanne Epfl |
High aspect ratio nanofibril materials
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
US9177795B2
(en)
|
2013-09-27 |
2015-11-03 |
Micron Technology, Inc. |
Methods of forming nanostructures including metal oxides
|
KR20160079114A
(ko)
|
2013-11-11 |
2016-07-05 |
아르모 바이오사이언시스 인코포레이티드 |
질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
|
US10428158B2
(en)
|
2014-03-27 |
2019-10-01 |
Dyax Corp. |
Compositions and methods for treatment of diabetic macular edema
|
WO2015175774A1
(en)
|
2014-05-14 |
2015-11-19 |
Trustees Of Dartmouth College |
Deimmunized lysostaphin and methods of use
|
AU2015264122B2
(en)
|
2014-05-21 |
2021-02-04 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
WO2015187295A2
(en)
|
2014-06-02 |
2015-12-10 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
SG10201902594QA
(en)
|
2014-09-24 |
2019-04-29 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
BR112017005736A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e formulações dos mesmos
|
WO2016064817A1
(en)
|
2014-10-22 |
2016-04-28 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
US10618970B2
(en)
|
2015-02-03 |
2020-04-14 |
Armo Biosciences, Inc. |
Method of treating cancer with IL-10 and antibodies that induce ADCC
|
WO2016149613A2
(en)
|
2015-03-18 |
2016-09-22 |
Massachusetts Institute Of Technology |
Selective mcl-1 binding peptides
|
CA2979847A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
AU2016268403A1
(en)
|
2015-05-28 |
2017-12-07 |
Armo Biosciences, Inc. |
Pegylated interleukin-10 for use in treating cancer
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US10464975B2
(en)
|
2015-07-02 |
2019-11-05 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
JP7053453B2
(ja)
|
2015-08-25 |
2022-04-12 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
疾患及び障害を治療するためのインターロイキン10の使用方法
|
CA2995479A1
(en)
|
2015-08-28 |
2017-03-09 |
Dana-Farber Cancer Institute, Inc. |
Peptides binding to bfl-1
|
CN108368161A
(zh)
|
2015-09-10 |
2018-08-03 |
艾瑞朗医疗公司 |
作为mcl-1调节剂的拟肽大环化合物
|
JP6184462B2
(ja)
*
|
2015-10-28 |
2017-08-23 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
BR112018011622A2
(pt)
|
2015-12-11 |
2018-11-27 |
Dyax Corp |
método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae
|
JP7105696B2
(ja)
|
2016-02-29 |
2022-07-25 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
|
WO2018017922A2
(en)
|
2016-07-22 |
2018-01-25 |
Massachusetts Institute Of Technology |
Selective bfl-1 peptides
|
CA3034532A1
(en)
|
2016-08-26 |
2018-03-01 |
Dana-Farber Cancer Institute, Inc. |
Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
|
WO2018170299A1
(en)
|
2017-03-15 |
2018-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of prokaryotic gene transcription and uses thereof
|
JP6361083B2
(ja)
*
|
2017-06-27 |
2018-07-25 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
EP3655105A2
(de)
|
2017-07-19 |
2020-05-27 |
Dana-Farber Cancer Institute, Inc. |
Stabilisierte antimikrobielle peptide zur behandlung von antibiotikaresistenten bakteriellen infektionen
|
EP3678484A4
(de)
|
2017-09-07 |
2021-03-24 |
KindHeart, Inc |
Modifizierte tierorgane zur verwendung in chirurgischen simulatoren
|
AU2018383633B2
(en)
|
2017-12-15 |
2024-05-16 |
Dana-Farber Cancer Institute, Inc. |
Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides
|
US20200354413A1
(en)
|
2017-12-15 |
2020-11-12 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
US11952432B2
(en)
|
2018-02-07 |
2024-04-09 |
Dana-Farber Cancer Institute, Inc. |
Cell-permeable stapled peptide modules for cellular delivery
|
EP3765852A1
(de)
|
2018-03-14 |
2021-01-20 |
Dana Farber Cancer Institute, Inc. |
Stabilisierte peptide für den nachweis von biomarkern
|
JP6500318B2
(ja)
*
|
2018-04-04 |
2019-04-17 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
WO2020060975A1
(en)
|
2018-09-17 |
2020-03-26 |
Massachusetts Institute Of Technology |
Peptides selective for bcl-2 family proteins
|
CA3135115A1
(en)
|
2019-04-18 |
2020-10-22 |
Dana-Farber Cancer Institute, Inc. |
Selective targeting of ubiquitin- and ubiquitin-like e1-activating enzymes by structurally-stabilized peptides
|
CN110759824A
(zh)
*
|
2019-09-30 |
2020-02-07 |
兰州交通大学 |
一种合成烯丙基脂肪醇聚氧乙烯醚羧酸(apea-3)的新方法
|
CN110668933A
(zh)
*
|
2019-09-30 |
2020-01-10 |
兰州交通大学 |
一种合成烯丙基脂肪醇聚氧乙烯醚羧酸(apea-7)的新方法
|
WO2021126827A1
(en)
|
2019-12-16 |
2021-06-24 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized oncolytic peptides and uses thereof
|
CA3162922A1
(en)
|
2019-12-20 |
2021-06-24 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized glucagon-like peptide 1 peptides and uses thereof
|
CA3173973A1
(en)
|
2020-03-04 |
2021-09-10 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized sars-cov-2 peptides and uses thereof
|
AU2021258205A1
(en)
|
2020-04-22 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ACE2 helix 1 peptides and uses thereof
|
US20230192789A1
(en)
|
2020-04-27 |
2023-06-22 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized and hdmx-selective p53 peptides and uses thereof
|
JP2023546561A
(ja)
|
2020-10-14 |
2023-11-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
ウイルスタンパク質および宿主タンパク質の分解のためのキメラコンジュゲートならびに使用方法
|
WO2022098848A1
(en)
|
2020-11-05 |
2022-05-12 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stabilized ebolavirus peptides and uses thereof
|
CA3231587A1
(en)
|
2021-09-08 |
2023-03-16 |
Dana-Farber Cancer Institute, Inc. |
Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof
|
WO2023215784A1
(en)
|
2022-05-04 |
2023-11-09 |
Dana-Farber Cancer Institute, Inc. |
Ebolavirus surface glycoprotein peptides, conjugates, and uses thereof
|